Lactoferrin pp 71-90 | Cite as

The Effects of Lactoferrin on Gram-Negative Bacteria

  • Richard T. EllisonIII
Part of the Advances in, Experimental Medicine and Biology book series (AEMB, volume 357)


Lactoferrin is an iron-binding protein found in human mucosal secretions as well as the specific granules of polymorphonuclear leukocytes. A variety of functions have been ascribed to the protein, and it appears to contribute to antimicrobial host defense. In particular, it has been shown to have direct effects on pathogenic microorganisms including bacteriostasis and the induction of microbial iron uptake systems. Still its overall physiologic role remains to be defined. It has appeared logical that antimicrobial activity of the protein arises from sequestration of environmental iron thereby causing nutritional deprivation in susceptible organisms. This argument is buttressed by the finding that selected highly virulent pathogens have evolved techniques to subvert this effect and use the protein as an iron source. However, recent observations indicate that the protein has additional properties that contribute to host defense. Work by several groups has shown that the protein synergistically interacts with immunoglobins, complement, and neutrophil cationic proteins against Gram-negative bacteria. Further, both the whole protein and a cationic N-terminus peptide fragment directly damage the outer membrane of Gram-negative bacteria suggesting a mechanism for the supplemental effects. This review will summarize these diverse observations with a consideration of how the in vitro work relates to the physiological role of the protein.


Permeability HPLC Magnesium Pneumonia Superoxide 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bullen JJ, Rogers HJ, Griffiths E. (1978) Role of iron in bacterial infection. Curr Top Microbiol Immunol 80:1–35.PubMedCrossRefGoogle Scholar
  2. 2.
    Moguilevsky N, Retegui LA, Masson PL. (1985) Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. Biochem J 229:353–359.Google Scholar
  3. 3.
    Baker EN, Rumball SV, Anderson BF. (1987) Transferons: insights into structure and function from studies on lactoferrin. Trends Biochem Sci 12:350–353.CrossRefGoogle Scholar
  4. 4.
    Aisen P, Leibman A. (1972) Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta 257:314–323.PubMedCrossRefGoogle Scholar
  5. 5.
    Groves ML. (1960) The isolation of a red protein from milk. J Am Chem Soc 82:3345–3360.CrossRefGoogle Scholar
  6. 6.
    Johansson B. (1960) Isolation of an iron-containing red protein from human milk. Acta Chem Scand 14:510–512.CrossRefGoogle Scholar
  7. 7.
    Bullen JJ. (1981) The significance of iron in infection. Rev Infect Dis 3:1127–1138.PubMedCrossRefGoogle Scholar
  8. 8.
    Masson PL, Heremans JF, Prignot JJ, Wauters G. (1966) Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax 21:538–544.PubMedCrossRefGoogle Scholar
  9. 9.
    Oram JD, Reiter B. (1968) Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochimica et Biophysica Acta 170:351–365.PubMedCrossRefGoogle Scholar
  10. 10.
    Bullen JJ, Rogers HJ, Leigh L. (1972) Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J 1:69–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Reiter B, Brock JH, Steel ED. (1975) Inhibition ofEscherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum-susceptible and serum-resistant strain of E. coli. Immunology 28:83–95.Google Scholar
  12. 12.
    Spik G, Cheron A, Montreuil J, Dolby JM. (1978) Bacteriostasis of a milk-sensitive strain of Escherichia coli by immunoglobulins and iron-binding proteins in association. Immunology 35:663–671.PubMedGoogle Scholar
  13. 13.
    Bishop JG, Schanbacher FL, Ferguson LC, Smith KL. (1976) In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferrin. Infect Immun 14:911–918.PubMedGoogle Scholar
  14. 14.
    Nonnecke BJ, Smith KL. (1984) Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth. J Dairy Sci 67:606–613.PubMedCrossRefGoogle Scholar
  15. 15.
    Griffiths E, Humphreys J. (1977) Bacteriostatic effect of human milk and bovine colostrum on Escherichia coli: importance of bicarbonate. Infect Immun 15:396–401.PubMedGoogle Scholar
  16. 16.
    Stuart J, Norrell S, Harrington JP. (1984) Kinetic effect of human lactoferrin on the growth of Escherichia coli O111. Int J Biochem 16:1043–1047.PubMedCrossRefGoogle Scholar
  17. 17.
    Stephens S, Dolby JM, Montreuil J, Spik G. (1980) Differences in inhibition of the growth of commensal and enteropathogenic strains of Escherichia coli by lactotransferrin and secretory immunoglobulin A isolated from human milk. Immunology 41:597–603.PubMedGoogle Scholar
  18. 18.
    Sawatzki G, Hoffman F, Kubanek B. The role of iron binding proteins, lactoferrin and transferrin, in Salmonella typhimurium infections in mice. In: Structure and function of iron storage and transport proteins, edited by Urushizaki, I. and et al, Elsevier Science Publishers B.V., 1983, p. 435-439.Google Scholar
  19. 19.
    Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z. (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection. in vivo.Br J Exp Path 70:697–704.Google Scholar
  20. 20.
    Czirok E, Milch H, Nemeth K, Gado I. (1990) In vitro and in vivo (LD50) effects of human lactoferrin on bacteria. Acta Microbiologica Hungarica 37:55–71.PubMedGoogle Scholar
  21. 21.
    LaForce FM, Boose DS, Ellison RTIII. (1986) Effect of aerosolized Escherichia coli and Staphylococcus aureus on iron and iron-binding proteins in lung lavage fluid. J Infect Dis 154:959–965.PubMedCrossRefGoogle Scholar
  22. 22.
    Finkelstein RA, Sciortino CV, Mclntosh MA. (1983) The role of iron in microbe-host interactions. Rev Infect Dis 5:S759–S777.PubMedCrossRefGoogle Scholar
  23. 23.
    Schryvers AB. (1989) Identification of the transferrin-and lactoferrin-binding proteins i. Haemophilus influenzae.J Med Microbiol 29:121–130.CrossRefGoogle Scholar
  24. 24.
    Lee BC, Bryan LE. (1989) Identification and comparative analysis of the lactoferrin and transferrin receptors among clinical isolates of gonococci. J Med Microbiol 28:199–204.PubMedCrossRefGoogle Scholar
  25. 25.
    Schryvers AB, Lee BC. (1988) Comparative analysis of the transferrin and lactoferrin binding proteins in the famil. Neisseriaceae.Can J Microbiol 35:409–415.CrossRefGoogle Scholar
  26. 26.
    Schryvers AB, Gonzalez GC. (1989) Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice. Infect Immun 57:2425–2429.PubMedGoogle Scholar
  27. 27.
    Ogunnariwo JA, Schryvers AB. (1990) Iron acquisition in Pasteurella haemolytica: expression and identification of a bovine-specific transferrin receptor. Infect Immun 58:2091–2097.PubMedGoogle Scholar
  28. 28.
    Schryvers AB, Morris LJ. (1988) Identification and characterization of the human lactoferrin-binding protein fro. Neisseria meningitidis.Infect Immun 56:1144–1149.Google Scholar
  29. 29.
    Blanton KJ, Biswas GD, Tsai J, Adams J, Dyer DW, Davis SM, Koch GG, Sen PK, Sparling PF. (1990) Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J. Bacteriol. 172:5225–5235.PubMedGoogle Scholar
  30. 30.
    Stevenson P, Williams P, Griffiths E. (1992) Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae type b. Infect Immun 60:2391–2396.PubMedGoogle Scholar
  31. 31.
    Banerjee-Bhatnagar N, Frasch CE. (1990) Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines. Infect Immun 58:2875–2881.PubMedGoogle Scholar
  32. 32.
    Padda JS, Schryvers AB. (1990) N-linked oligosaccharides of human transferrin are not required for binding to bacterial transferrin receptors. Infect Immun 58:2972–2976.PubMedGoogle Scholar
  33. 33.
    Dolby JM, Stephens S. (1983) Antibodies to Escherichia coli O antigens and the in vitro bacteriostatic properties of human milk and its IgA. Acta Paediatr Scand 72:577–582.PubMedCrossRefGoogle Scholar
  34. 34.
    Pollock JJ, Shoda J, McNamara TF, Cho M-I, Campbell A, Iacono VJ. (1984) In vitro and in vivo studies of cellular lysis of oral bacteria by a lysozyme-protease-inorganic monovalent anion antibacterial system. Infect Immun 45:610–617.PubMedGoogle Scholar
  35. 35.
    Wright DG, Gallin JI. (1979) Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol 123:285–294.PubMedGoogle Scholar
  36. 36.
    Joiner KA, Ganz T, Albert J, Rotrosen D. (1989) The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constitutents into neutrophil phagosomes. J Leukocyte Biol. 109:2771–2782.Google Scholar
  37. 37.
    Skerlavaj B, Romeo D, Gennaro R. (1990) Rapid membrane permeabilization and inhibition of vital functions of Gram-negative bacteria by bactenecins. Infect Immun 58:3724–3730.PubMedGoogle Scholar
  38. 38.
    Lima MF, Kierszenbaum F. (1985) Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. J Immunol 134:4176–4183.Google Scholar
  39. 39.
    Lima MF, Kierszenbaum F. (1987) Lactoferrin effects on phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. J Immunol 139:1647–1651.PubMedGoogle Scholar
  40. 40.
    Byrd TF, Horwitz MA. (1991) Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.J Clin Invest 88:1103–1112.PubMedCrossRefGoogle Scholar
  41. 41.
    Byrd TF, Horwitz MA. (1989) Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting availability of iron. J Clin Invest 83:1457–1465.PubMedCrossRefGoogle Scholar
  42. 42.
    Britigan BE, Serody JS, Hayek MB, Charniga LM, Cohen MS. (1991) Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation. J Immunol 147:4271–4277.PubMedGoogle Scholar
  43. 43.
    Rainard P. (1986) Bacteriostasis of Escherichia coli by bovine lactoferrin, transferrin and immunoglobulins (IgG1, IgG2, IgM) acting alone or in combination. Vet Microbiol 11:103–115.PubMedCrossRefGoogle Scholar
  44. 44.
    Rogers HJ, Synge C. (1978) Bacteriostatic effect of human milk on Escherichia coli: the role of IgA. Immunology 34:19–28.PubMedGoogle Scholar
  45. 45.
    Fitzgerald SP, Rogers HJ. (1980) Bacteriostatic effect of serum: role of antibody to lipopolysaccharide. Infect Immun 27:302–308.PubMedGoogle Scholar
  46. 46.
    Arnold RR, Cole MF, McGhee JR. (1977) A bactericidal effect for human lactoferrin. Science 197:263–265.PubMedCrossRefGoogle Scholar
  47. 47.
    Arnold RR, Brewer M., Gauthier JJ. (1980) Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 28:893–898.PubMedGoogle Scholar
  48. 48.
    Arnold RR, Russell JE, Champion WJ, Brewer M., Gauthier JJ. (1982) Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun 35:792–799.PubMedGoogle Scholar
  49. 49.
    Bortner CA, Miller RD, Arnold RR. (1986) Bactericidal effect of lactoferrin on Legionella pneumophila. Infect Immun 51:373–377.PubMedGoogle Scholar
  50. 50.
    Kalmar JR, Arnold RR. (1988) Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun 56:2552–2557.PubMedGoogle Scholar
  51. 51.
    Bortner CA, Arnold RR, Miller RD. (1989) Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organism. Can J Microbiol 35:1048–1051.PubMedCrossRefGoogle Scholar
  52. 52.
    Motley MA, Arnold RR. (1987) Cofactor requirements for expression of lactoferrin bactericidal activity on enteric bacteria. Adv Exp Med Biol 216A:591–599.PubMedCrossRefGoogle Scholar
  53. 53.
    Hammill R, Brown D, Watson D, Musher D, Baughn R. (1987) The observed bactericidal effect of lactoferrin is an artifact of pH. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy Abstract 560.Google Scholar
  54. 54.
    Dalmastri C, Valenti P, Visca P, Vittorioso P, Orsi N. (1988) Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microbiologica 11:225–230.PubMedGoogle Scholar
  55. 55.
    Visca P, Dalmastri C, Verzili D, Antonini G, Chiancone E, Valenti P. (1990) Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med Microbiol Immunol 179:323–333.PubMedCrossRefGoogle Scholar
  56. 56.
    Naidu SS, Erdei J, Czirok E, Kalfas S, Gado I, Thoren A, Forsgren A, Naidu AS. (1991) Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. APMIS 99:1142–1150.PubMedCrossRefGoogle Scholar
  57. 57.
    Kishore AR, Erdei J, Naidu SS, Falsen E, Forsgren A, Naidu AS. (1991) Specific binding of lactoferrin t. Aeromonas hydrophila.FEMS Microbiol.Lett. 83:115–119.CrossRefGoogle Scholar
  58. 58.
    Tigyi Z, Kishore AR, Maeland JA, Forsgren A, Naidu AS. (1992) Lactoferrin-binding proteins i. Shigella flexneri.Infect Immun 60:2619–2626.Google Scholar
  59. 59.
    Gado I, Erdei J, Laszlo VG, Paszti J, Czirok E, Kontrohr T, Toth I, Forsgren A, Naidu AS. (1991) Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli. Antimicrob. Agents Chemother. 35:2538–2543.CrossRefGoogle Scholar
  60. 60.
    Ellison RT III, Giehl TJ, LaForce FM. (1988) Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56:2774–2781.PubMedGoogle Scholar
  61. 61.
    Ellison RT III, LaForce FM, Giehl TJ, Boose DS, Dunn BE. (1990) Lactoferrin and transferrin damage of the Gram-negative outer membrane is modulated by Ca2+ and Mg2+. J Gen Microbiol 136:1437–1446.PubMedGoogle Scholar
  62. 62.
    Ellison RT III, Giehl TJ. (1991) Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88:1080–1091.PubMedCrossRefGoogle Scholar
  63. 63.
    Coughlin RT, Tonsager S, McGroarty EJ. (1983) Quantitation of metal cations bound to membranes and extracted lipopolysaccharide of E. coli. Biochemistry 22:2002–2007CrossRefGoogle Scholar
  64. 64.
    Leive L. (1974) The barrier function of the Gram-negative envelope. Ann NY Acad Sci 235:10–127.CrossRefGoogle Scholar
  65. 65.
    Nikaido H, Vaara M. (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1–32.PubMedGoogle Scholar
  66. 66.
    Joiner KA. (1985) Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of bactericidal antibody. Curr Top Microbiol Immunol 121:99–133.PubMedCrossRefGoogle Scholar
  67. 67.
    Bryan CS. (1974) Sensitization of E. coli to the serum bactericidal system and to lysozyme by ethyle-neglycoltetraacetic acid. Proc Soc Exp Biol Med 1451:1431–1433.Google Scholar
  68. 68.
    Vaara M., Vaara T. (1983) Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother 24:114–122.PubMedCrossRefGoogle Scholar
  69. 69.
    Mannion BA, Weiss J, Elsbach P. (1990) Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest 85:853–860.PubMedCrossRefGoogle Scholar
  70. 70.
    Lehrer RI, Barton A, Daher K, Harwig SSL, Ganz T, Selsted ME. (1989) Interaction of human defensins with Escherichia coli. Mechanisms of bactericidal activity. J Clin Invest 84:553–561.PubMedCrossRefGoogle Scholar
  71. 71.
    Hancock REW, Wong PGW. (1984) Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother 26:48–52.PubMedCrossRefGoogle Scholar
  72. 72.
    Vaara M., Viljanen P. (1985) Binding of polymyxin B nonapeptide to Gram-negative bacteria. Antimicrob Agents Chemother 27:548–554.PubMedCrossRefGoogle Scholar
  73. 73.
    Boman HG. (1991) Antibacterial peptides: key components needed in immunity. Cell 65:205–207.PubMedCrossRefGoogle Scholar
  74. 74.
    Lehrer RI, Ganz T. (1990) Antimicrobial polypeptides of human neutrophils. Blood 76:2169–2181.PubMedGoogle Scholar
  75. 75.
    Lehrer RI, Ganz T, Selsted ME. (1991) Defensins: endogenous antibiotic peptides of animal cells. Cell 64:229–230.PubMedCrossRefGoogle Scholar
  76. 76.
    Goldman RC, Leive L. (1980) Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli O111 and Salmonella typhimurium LT2. Eur J Biochem 107:145–153.PubMedCrossRefGoogle Scholar
  77. 77.
    Hukari RI, Helander M., Vaara M. (1986) Chain length heterogeneity of lipopolysaccharide released from Salmonella typhimurium by ethylenediaminetetraacetic acid or polycations. Eur J Biochem 154:673–676.PubMedCrossRefGoogle Scholar
  78. 78.
    Joiner KA, Grossman N, Schmetz M., Leive L. (1986) C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation b. Salmonella montevideo.J Immunol 136:710–715.Google Scholar
  79. 79.
    Samson RR, Mirtle C, McClelland DBL. (1979) Secretory IgA does not enhance the bacteriostatic effects of iron-binding or vitamin B12-binding proteins in human colostrum. Immunology 38:367–373.PubMedGoogle Scholar
  80. 80.
    Boesman-Finkelstein M, Finkelstein RA. (1985) Antimicrobial effects of human milk: inhibitory activity on enteric pathogens. FEMS Microbiol Lett 27:167–174.CrossRefGoogle Scholar
  81. 81.
    Rocque WJ, Fesik SW, Haug A, McGroarty EJ. (1988) Polycation binding to isolated lipopolysaccharide from antibiotic-hypersusceptible mutant strains o. Escherichia coli.Antimicrob Agents Chemother 32:308–313.CrossRefGoogle Scholar
  82. 82.
    Peterson AA, Fesik SW, McGroarty EJ. (1987) Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli an. Salmonella typhimurium.Antimicrob Agents Chemother 31:230–237.CrossRefGoogle Scholar
  83. 83.
    Danner RL, Joiner KA, Rubin M., Patterson WH, Johnson N, Ayers KM, Parrillo JE. (1989) Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother 33:1428–1434.PubMedCrossRefGoogle Scholar
  84. 84.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. (1990) Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144:662–666.PubMedGoogle Scholar
  85. 85.
    Miyazawa K, Mantel C, Lu L, Morrison DC, Broxmeyer HE. (1991) Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J Immunol 146:723–729.PubMedGoogle Scholar
  86. 86.
    Cohen MS, Mao J, Rasmussen GT, Serody JS, Britigan BE. (1992) Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation. J Infect Dis 166:1375–1378.PubMedCrossRefGoogle Scholar
  87. 87.
    Brade L, Brandenburg K, Kuhn H-M, Kusumoto S, Macher I, Rietschel ET, Brade H. (1987) The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun 55:2636–2644.PubMedGoogle Scholar
  88. 88.
    Rocque WJ, Coughlin RT, McGroarty EJ. (1987) Lipopolysaccharide tightly bound to porin monomers and trimers from Escherichia coli K-12. J Bacteriol 169:4003–4010.PubMedGoogle Scholar
  89. 89.
    Anderson BF, Baker HM, Norris GE, Rice DW, Baker EN. (1989) Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 angstrom resolution. J Mol Biol 209:711–734.PubMedCrossRefGoogle Scholar
  90. 90.
    Tomita M, Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K. (1991) Potent antibacterial peptides generated by pepsin digestion of lactoferrin. J Dairy Sci 74:4137–4142.PubMedCrossRefGoogle Scholar
  91. 91.
    Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. (1992) Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121:130–136.PubMedCrossRefGoogle Scholar
  92. 92.
    Pierce A, Colavizza D, Benaissa M., Maes P, Tartar A, Montreuil J, Spik G. (1991) Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem 196:177–184.PubMedCrossRefGoogle Scholar
  93. 93.
    Goodman RE, Schanbacher FL. (1991) Bovine lactoferrin mRNA: sequence, analysis, and expression in the mammary gland. Biochem Biophys Res Comm 180:75–84.PubMedCrossRefGoogle Scholar
  94. 94.
    Yamauchi K, Tomita M., Giehl TJ, Ellison RTIII. (1993) Antibacterial activity of Lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61:719–728.PubMedGoogle Scholar
  95. 95.
    Baker EN, Anderson BF, Baker HM, Haridas M., Jameson GB, Norris GE, Rumball SV, Smith CA. (1991) Structure, function and flexibility of human lactoferrin. Int J Biol Macromol. 13:122–129.PubMedCrossRefGoogle Scholar
  96. 96.
    Pollack C, Straley SC, Klempner MS. (1986) Probing the phagolysosomal environment of human macrophages with a Ca-responsive operon fusion i. Yersinia pestis.Nature (Lond.) 322:834–836.CrossRefGoogle Scholar
  97. 97.
    Weiss J, Muello K, Victor M., Elsbach P. (1984) The role of lipopolysaccharides in the action of the bactericidal/permeability increasing neutrophil protein on the bacterial envelope. J Immunol 132:3109–3115.PubMedGoogle Scholar
  98. 98.
    Campanelli D, Detmers PA, Nathan CF, Gabay JE. (1990) Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J Clin Invest 85:90–915.CrossRefGoogle Scholar
  99. 99.
    Odeberg H, Olsson I. (1976) Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun 14:1269–1275.PubMedGoogle Scholar
  100. 100.
    Lehrer RI, Ganz T, Szklarek D, Selsted ME. (1988) Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest 81:1829–1835.PubMedCrossRefGoogle Scholar
  101. 101.
    Diamond G, Zasloff M, Eck H, Brasseur M., Maloy WL, Bevins CL. (1991) Trachéal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 88:3952–3956.PubMedCrossRefGoogle Scholar
  102. 102.
    Eisenhauer PB, Harwig SSSL, Lehrer RI. (1992) Cryptdins: Antimicrobial defensins of the murine small intestine. Infect Immun 60:3556–3565.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Richard T. EllisonIII
    • 1
  1. 1.Division of Infectious Diseases Department of MedicineUniversity of Massachusetts School of MedicineWorcesterEngland

Personalised recommendations